Active, Not Recruiting
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
NCT03899792
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
- Locations
-
- Childrens Hospital of Los Angeles Los Angeles, California, United States
- The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
- Nemours Children's Health Orlando, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States